Moderna, Inc. (MRNA)

40.56 +0.96 (+2.42%) USD  |  NASDAQ  |  Jan 14, 13:32
More

Moderna Total Expenses (% of Annual Revenues)

Total Expenses (% of Annual Revenues) Chart

View Total Expenses (% of Annual Revenues) for MRNA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (% of Annual Revenues) Range, Past 5 Years

View Total Expenses (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Annual Revenues) Benchmarks

View Total Expenses (% of Annual Revenues) Benchmarks
Start Trial
Eli Lilly & Co. Upgrade
Merck & Co., Inc. Upgrade
Pfizer Inc. Upgrade
Novavax, Inc. Upgrade
Johnson & Johnson Upgrade